Takeda Pharmaceutical Company Limited Acquisitions Through Business Combinations Other Provisions
Takeda Pharmaceutical Company Limited (TAK) reported Acquisitions Through Business Combinations Other Provisions of JPY 273.36 billion for the 12-month period ending 2019-03-31, per its 20-F filed 2020-06-24.
Discontinued › Notes
ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions · last filed 2020-06-24
| Period end | Acquisitions Through Business Combinations Other Provisions 12 month | Acquisitions Through Business Combinations Other Provisions 12 month as first filed |
|---|---|---|
| 2019-03-31 | 273.36B JPY 20-F · filed 2020-06-24 | 278.99B JPY 20-F · filed 2019-06-27 |